In a recent case report authored by Brock Daughtry et al., the innovative utilization of extracorporeal membrane oxygenation (ECMO) and extracorporeal life support (ECLS) devices is showcased in the management of acute heart failure precipitated by severe mitral regurgitation secondary to COVID-19 pneumonia. The patient was stabilized and underwent open mitral valve replacement through a combination of venoarterial (VA) ECMO…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest